Pharmaceutical Industry Information Portal

HomeDiscovery and Development

Discovery and Development

Roche teams up with research institutions for new Alzheimer’s trial

Roche announced a new Phase III Alzheimer’s disease prevention trial SKYLINE with gantenerumab, an investigational anti-amyloid antibody that is administered subcutaneously. Roche intends to...

CureVac establishes RNA printer-specific company

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced that it has established...

U.S. FDA approves medicine for the treatment of relapsed or refractory multiple myeloma

The Janssen Pharmaceutical Companies of Johnson & Johnson and its China-focused partner Legend Biotech Corp. developed a therapy to treat a type of white blood...

Amorphous Solid Dispersion – a new dosage form

RUDN University scientists together with colleagues from Switzerland proved in a clinical trial the effectiveness of a new dosage form — amorphous solid dispersion....

WHO announces second global biomanufacturing training hub

Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub. The World Health Organization (WHO), the Republic of Korea and...

Six African countries to receive mRNA vaccine technology

Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia will be the first African countries to receive the technology required to produce mRNA vaccines on...
spot_img

Expert Articles

spot_img